Statistics
Publications
35
Citations
5.7K
H-Index
29
Active since
1996
Seth A. Ettenberg is an author at Novartis (United States) specializing in medicine, cell biology, and cell signaling.
Publications per year
1996–2022
35
35
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
Maccon Keane, Seth A. Ettenberg, Marion M. Nau et al. · PubMed · 1999 · 557 citations
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
Mariateresa Fulciniti, Pierfrancesco Tassone, Teru Hideshima et al. · Blood · 2009 · 395 citations · Full text
Mauricio Cuello, Seth A. Ettenberg, Amy S. Clark et al. · PubMed · 2001 · 372 citations
1–5 of 35